Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel
R Banerjee, Y Biru, CE Cole, B Faiman, S Midha… - Blood cancer …, 2024 - nature.com
Many studies have documented racial, socioeconomic, geographic, and other disparities for
United States (US) patients with multiple myeloma pertaining to diagnosis and frontline …
United States (US) patients with multiple myeloma pertaining to diagnosis and frontline …
A systematic epidemiological trends analysis study in global burden of multiple myeloma and 29 years forecast
Q Hou, X Li, H Ma, D Fu, A Liao - Scientific Reports, 2025 - nature.com
Multiple myeloma is a prevalent hematologic cancer. This investigation analyzes the latest
global, regional, and national data from the Global Burden of Diseases, Injuries, and Risk …
global, regional, and national data from the Global Burden of Diseases, Injuries, and Risk …
Disparities in time to treatment with oral antimyeloma medications
This retrospective cohort study used Taussig Cancer Center's Myeloma Patient Registry to
identify adults with multiple myeloma diagnosed between January 2017-December 2021 …
identify adults with multiple myeloma diagnosed between January 2017-December 2021 …
A Real-World Analysis on Access to Triplet and Quadruplet Therapy in Newly Diagnosed Multiple Myeloma Patients in the United States
L Saba, CL Fu, H Liang, CP Chaulagain - Clinical Lymphoma Myeloma …, 2025 - Elsevier
Background Disparities in access to triplet and quadruplet therapy for multiple myeloma
(MM) patients remain a challenge in the United States. We aimed to investigate …
(MM) patients remain a challenge in the United States. We aimed to investigate …
Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities
PURPOSE Little is known about the role of social determinants of health (SDOH) in the
utilization of novel treatments among patients with newly diagnosed multiple myeloma …
utilization of novel treatments among patients with newly diagnosed multiple myeloma …
Income and education affect prognosis and treatment in symptomatic myeloma
G Larfors, K Carlson, C Day, S Einarsdottir… - Annals of …, 2025 - Springer
Despite advancements in multiple myeloma treatment, prognostic variability persists. We
investigated the impact of income and education on treatment and survival in a country with …
investigated the impact of income and education on treatment and survival in a country with …
[HTML][HTML] Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma
Abstract Purpose Continuous Medicaid coverage prior to a cancer diagnosis has been
associated with earlier detection and better outcomes, for patients with solid tumors. In this …
associated with earlier detection and better outcomes, for patients with solid tumors. In this …
Impact of Social Determinants of Health on Survival Outcomes in Multiple Myeloma Patients at a Major Cancer Center
E Abdalla, M Alharbi, S Bawek, C Forbes, I Lund, H Yu… - Blood, 2024 - Elsevier
Introduction: Social determinants of health (SDOH), including ethnic background, education,
housing, employment, healthcare access, and economic stability, have been shown to …
housing, employment, healthcare access, and economic stability, have been shown to …
Trends in the global burden of multiple myeloma, between 1990 and 2021, an up-to-date analysis from the Global Burden of Disease Study 2021
Q Hou, X Li, H Ma, D Fu, A Liao - 2024 - researchsquare.com
Background Multiple myeloma (MM) is a prevalent hematologic cancer. This investigation
analyzes the latest global, regional, and national data from the Global Burden of Diseases …
analyzes the latest global, regional, and national data from the Global Burden of Diseases …